1. Cancer vaccines: clinical applications: Partially purified tumor antigen vaccines;Bystryn,1995
2. Antibody response and tumor growth in syngeneic mice immunized to partially purified B16 melanoma associated antigens;Bystryn;J Immunol,1978
3. HLA-independent heterogeneity of CD8+ T cell responses to MAGE-3, Melan A/MART-1, gp100, tyrosinase, MC1R and TRP-2 in vaccine-treated melanoma patients;Reynolds;J Immunol,1998
4. Improved survival of melanoma patients with an antibody response to immunization to a polyvalent melanoma vaccine;Miller;Cancer,1995
5. Vaccine therapy for malignant melanoma;Morton;CA Cancer J Clin,1996